ClearPoint Neuro, Inc. 8-K

What Happened

• On January 12, 2026, ClearPoint Neuro, Inc. announced preliminary, unaudited financial results for the fourth fiscal quarter ended December 31, 2025 via a press release. The company furnished that press release as Exhibit 99.1 to its Form 8‑K filed under Item 2.02. The Form 8‑K was signed by CFO Danilo D'Alessandro.

Key Details

• Filing date: January 12, 2026.
• Reporting period: fourth quarter ended December 31, 2025.
• Nature of results: described as preliminary and unaudited.
• Exhibits included: Exhibit 99.1 (press release) and Exhibit 104 (cover page interactive XBRL).

Why It Matters

• This filing signals that ClearPoint is releasing its quarterly earnings and revenue information; preliminary (unaudited) results can affect short‑term investor expectations and the stock price. Because the numbers are unaudited and preliminary, they may be revised in subsequent filings (e.g., quarterly or annual reports). Investors should read the furnished press release for the specific revenue and earnings figures and watch for follow‑up filings or management commentary for finalized, audited results.